Form 4: Solid Biosciences Director Ilan Ganot Reports Stock Transactions
SEC Form 4 Filing
Director Ilan Ganot reports acquisition and disposal of Solid Biosciences Inc. stock, including transactions by his wife to cover withholding taxes.
Summary
- On February 13, 2025, Ilan Ganot's wife acquired 4,861 shares of Solid Biosciences Inc. common stock indirectly.
- On February 14, 2025, Ilan Ganot's wife sold 1,711 shares of common stock at $3.96 per share to cover withholding taxes related to vesting restricted stock units.
- Following these transactions, Ilan Ganot directly owns 98,690 shares and indirectly owns 14,839 shares through his wife, and 19,394 shares through a trust.
- He also indirectly owns 14,583 derivative securities through his wife.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports stock transactions, including a sale to cover taxes, which is a common practice. There's no indication of positive or negative outlook based solely on this filing.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect a broader industry trend but is specific to the individual's financial decisions and compensation structure within Solid Biosciences.
Key Dates
| Date | Description |
|---|---|
| 2017-03-03 | Date of the Ilan Ganot 2017 Irrevocable Trust. |
| 2024-02-13 | Grant Date of 19,444 restricted stock units to Ms. Ganot, vesting in four equal installments on the anniversary of the Grant Date. |
| 2024-09-25 | Date Ms. Ganot adopted a durable automatic sales instruction letter effecting the sell-to-cover election. |
| 2025-02-13 | Date of restricted stock units converting into common stock and indirect acquisition of 4,861 shares by Ilan Ganot's wife. |
| 2025-02-14 | Date of sale of 1,711 shares by Ilan Ganot's wife at $3.96 per share. |
| 2025-02-18 | Date of signature of the report by attorney-in-fact for Ilan Ganot. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.